MedTrace Logo

Ex-vivo Evaluation of the Effect of 2 Probiotic Solutions (Lactibiane ATB and Lactibiane Enfant) and 5 Classes of Drugs on the Intestinal Microbiota

NCT06114303 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 14

Last updated 2025-12-02

No results posted yet for this study

Summary

The objective is to test ex-vivo the effects of two probiotic solutions (Lactibiane ATB and Lactibiane Enfant) and five classes of drugs (antibiotic, proton pump inhibitor, non-steroidal anti-inflammatory, anxiolytic and anti-depressant) on microbial microcosms derived from human stool samples (from adults and children) re-cultured under anaerobic conditions.

Conditions

Interventions

OTHER

Stool sampling

1 stool sample is taken during the study with a stool sample kit

Sponsors & Collaborators

  • Université Paris-Saclay

    collaborator OTHER

  • Larena SAS

    lead INDUSTRY

Eligibility

Min Age
1 Year
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-03-14
Primary Completion
2025-06-16
Completion
2025-06-16

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06114303 on ClinicalTrials.gov